These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27403785)

  • 21. Brivaracetam UCB.
    Malawska B; Kulig K
    Curr Opin Investig Drugs; 2005 Jul; 6(7):740-6. PubMed ID: 16044671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of rational polypharmacy to treat epilepsy.
    Ferrendelli JA
    Epilepsy Res Suppl; 1996; 11():239-43. PubMed ID: 9294741
    [No Abstract]   [Full Text] [Related]  

  • 23. Perampanel (Fycompa) for epilepsy.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):9-10. PubMed ID: 24662975
    [No Abstract]   [Full Text] [Related]  

  • 24. Sulphuric body odor under therapy with Brivaracetam.
    Zahnert F; Menzler K; Knake S
    Seizure; 2018 Dec; 63():91-92. PubMed ID: 30468963
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of polypharmacy: prediction of drug interactions.
    Mather GG; Levy RH
    Epilepsy Res Suppl; 1996; 11():113-21. PubMed ID: 9294732
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of trigeminal neuralgia with spasmolytics].
    Savitskaia ON
    Sov Med; 1974 Sep; 0(9):21-5. PubMed ID: 4411359
    [No Abstract]   [Full Text] [Related]  

  • 27. Brivaracetam for the treatment of epilepsy in adults.
    Mula M
    Expert Rev Neurother; 2014 Apr; 14(4):361-5. PubMed ID: 24625006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy in infancy: answering the call.
    Thio LL; Dodson WE
    Neurology; 2010 Mar; 74(9):708-9. PubMed ID: 20107140
    [No Abstract]   [Full Text] [Related]  

  • 29. Applications of computer assisted quantum pharmacology calculations in devising anticonvulsant rational polypharmacy strategies.
    Weaver DF
    Epilepsy Res Suppl; 1996; 11():95-111. PubMed ID: 9294731
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiologically based pharmacokinetic/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy.
    Brochot A; Zamacona M; Stockis A
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):256-62. PubMed ID: 20102365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of newer diagnostic techniques in patient management.
    Stefan H
    Epilepsy Res Suppl; 1996; 11():199-209. PubMed ID: 9294737
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation and management of epilepsy today: introductory remarks.
    Kanner AM
    Semin Neurol; 2008 Jul; 28(3):273-5. PubMed ID: 18777473
    [No Abstract]   [Full Text] [Related]  

  • 33. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug treatment of convulsive disorders.
    Millichap JG
    N Engl J Med; 1972 Mar; 286(9):464-9. PubMed ID: 4333276
    [No Abstract]   [Full Text] [Related]  

  • 35. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.
    Brodie MJ
    CNS Drugs; 2017 Feb; 31(2):135-147. PubMed ID: 28101765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crossreactivity in antiepileptic drug monitoring: Reply to: Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-a monocenter survey.
    Strasser B; Tomasits J
    Seizure; 2022 Jan; 94():115-116. PubMed ID: 34894439
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate drug targets for prevention or modification of epilepsy.
    Varvel NH; Jiang J; Dingledine R
    Annu Rev Pharmacol Toxicol; 2015; 55():229-47. PubMed ID: 25196047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies.
    Tian X; Yuan M; Zhou Q; Wang X
    Expert Opin Pharmacother; 2015; 16(12):1755-67. PubMed ID: 26165169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.